GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnteoTech Ltd (ASX:ADO) » Definitions » Loans Receivable

AnteoTech (ASX:ADO) Loans Receivable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is AnteoTech Loans Receivable?

AnteoTech's Loans Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


AnteoTech Loans Receivable Historical Data

The historical data trend for AnteoTech's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnteoTech Loans Receivable Chart

AnteoTech Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AnteoTech Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AnteoTech Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


AnteoTech Loans Receivable Related Terms

Thank you for viewing the detailed overview of AnteoTech's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


AnteoTech Business Description

Traded in Other Exchanges
N/A
Address
4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.

AnteoTech Headlines

No Headlines